why choose us

First received: May 17, 2023

Clinical Trial: A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Double-blind, Randomized, Placebo-controlled, Multi-part, Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

Brief Summary: The purposes of this study are to:Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects.Find out how much CK-4021586 is in the blood after a single dose and multiple doses.Determine the effect different doses of CK-4021586 on the pumping function of the heart.Determine the effect of food in the stomach on how much CK-4021586 is in the blood after a single dose.

Read more